When making decisions and judgments, humans can fall into common "traps," known as cognitive biases. A cognitive bias is ...
Participating Medicare Part D plans can officially begin covering weight-loss treatment in 2027. The initiative falls under CMS’ voluntary “Better Approaches to Lifestyle and Nutrition for ...
GLP-1 drugs are meant to treat metabolic diseases like diabetes and obesity. But as they become more available, some people might choose to use them even if they're not currently overweight. NPR's ...
X is putting its money where its mouth is. The Elon Musk-owned social media platform just pledged it will give $1 million to the user who creates the most popular long-form post using its newly ...
For women with obesity, GLP-1 medications like Ozempic and Wegovy may help address the metabolic challenges that often intensify during midlife. The hormonal shifts of perimenopause and menopause can ...
In this photo, Humana chief executive officer Jim Rechtin speaks at the Forbes Healthcare Summit December 4, 2025 at NYU Langone Health in New York in an appearance with the entrepreneur Mark Cuban on ...
Derek Bartel didn’t recognize himself. Looking back at photos from a recent trip, he was convinced his wife had pulled a prank. “Oh my god, is that me?” Bartel, 39, recalled thinking, certain she’d ...
Health expert talks what to know before using GLP-1s for weight use Trump pulls US out of more than 30 UN bodies Fresno County farmer buys land, not for what's planted, but for what's underneath With ...
Several research studies, either in progress or in planning stages, are testing whether GLP-1 agonists can help people who have symptoms of an alcohol use disorder reduce drinking. The goal of the ...
With the launch of Apple's newest iPhone line in September came the release of arguably its biggest OS upgrade yet: iOS 26. Its features are both stunning and polarizing (check out our review of this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results